MedEquities Realty Trust Inc (NYSE:MRT) – Investment analysts at KeyCorp issued their Q1 2018 earnings per share estimates for shares of MedEquities Realty Trust in a research report issued on Thursday. KeyCorp analyst J. Sadler forecasts that the financial services provider will post earnings per share of $0.32 for the quarter. KeyCorp currently has a “Buy” rating and a $13.00 target price on the stock.

Several other brokerages also recently commented on MRT. B. Riley reaffirmed a “buy” rating on shares of MedEquities Realty Trust in a research note on Wednesday, November 1st. Capital One Financial began coverage on shares of MedEquities Realty Trust in a research note on Monday, October 23rd. They set an “equal weight” rating and a $13.00 price objective for the company. Zacks Investment Research downgraded shares of MedEquities Realty Trust from a “buy” rating to a “hold” rating in a research note on Wednesday, January 3rd. Finally, ValuEngine raised shares of MedEquities Realty Trust from a “hold” rating to a “buy” rating in a research note on Friday, December 1st. Two analysts have rated the stock with a hold rating and five have given a buy rating to the stock. The stock currently has a consensus rating of “Buy” and an average price target of $13.00.

Shares of MedEquities Realty Trust (NYSE:MRT) remained flat at $$10.84 during trading hours on Monday. 145,200 shares of the stock traded hands, compared to its average volume of 192,920. The stock has a market capitalization of $344.23 and a P/E ratio of 27.79. MedEquities Realty Trust has a 52-week low of $10.06 and a 52-week high of $13.06.

MedEquities Realty Trust (NYSE:MRT) last issued its quarterly earnings data on Tuesday, November 7th. The financial services provider reported $0.17 EPS for the quarter, missing the consensus estimate of $0.30 by ($0.13). The firm had revenue of $15.77 million for the quarter, compared to the consensus estimate of $15.49 million. MedEquities Realty Trust had a net margin of 35.61% and a return on equity of 5.88%.

In related news, Director Randy L. Churchey purchased 5,300 shares of the firm’s stock in a transaction that occurred on Monday, November 20th. The stock was bought at an average cost of $10.87 per share, with a total value of $57,611.00. Following the completion of the purchase, the director now directly owns 46,776 shares in the company, valued at $508,455.12. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CEO John W. Mcroberts purchased 18,000 shares of the firm’s stock in a transaction that occurred on Friday, November 17th. The stock was bought at an average cost of $10.74 per share, with a total value of $193,320.00. The disclosure for this purchase can be found here. Over the last three months, insiders purchased 23,600 shares of company stock valued at $254,129. 2.50% of the stock is owned by insiders.

Hedge funds have recently added to or reduced their stakes in the stock. California State Teachers Retirement System raised its stake in MedEquities Realty Trust by 24.5% in the second quarter. California State Teachers Retirement System now owns 50,800 shares of the financial services provider’s stock worth $641,000 after buying an additional 10,000 shares in the last quarter. Los Angeles Capital Management & Equity Research Inc. bought a new position in MedEquities Realty Trust in the third quarter worth about $411,000. Prudential Financial Inc. raised its stake in MedEquities Realty Trust by 5.4% in the third quarter. Prudential Financial Inc. now owns 2,658,837 shares of the financial services provider’s stock worth $31,242,000 after buying an additional 136,499 shares in the last quarter. American Century Companies Inc. raised its stake in MedEquities Realty Trust by 11.2% in the third quarter. American Century Companies Inc. now owns 1,726,208 shares of the financial services provider’s stock worth $20,283,000 after buying an additional 174,261 shares in the last quarter. Finally, Asset Management One Co. Ltd. raised its stake in MedEquities Realty Trust by 40.8% in the third quarter. Asset Management One Co. Ltd. now owns 62,539 shares of the financial services provider’s stock worth $747,000 after buying an additional 18,111 shares in the last quarter. 93.19% of the stock is owned by institutional investors.

TRADEMARK VIOLATION WARNING: “Research Analysts Offer Predictions for MedEquities Realty Trust Inc’s Q1 2018 Earnings (MRT)” was first published by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are reading this news story on another publication, it was copied illegally and reposted in violation of United States & international copyright and trademark laws. The legal version of this news story can be viewed at https://www.thecerbatgem.com/2018/01/17/research-analysts-offer-predictions-for-medequities-realty-trust-incs-q1-2018-earnings-mrt.html.

About MedEquities Realty Trust

MedEquities Realty Trust, Inc is a real estate investment trust (REIT). The Company invests in a diversified mix of healthcare properties and healthcare-related real estate debt investments. The Company invests primarily in real estate across the acute and post-acute spectrum of care. It focuses on investing in various types of healthcare properties, including acute care hospitals; skilled nursing facilities; short-stay surgical and specialty hospitals, which focus on orthopedic, heart and other dedicated surgeries and specialty procedures; dedicated specialty hospitals, such as inpatient rehabilitation facilities, long-term acute care hospitals and facilities providing psychiatric care; physician clinics; diagnostic facilities; outpatient surgery centers, and facilities that support these services, such as medical office buildings.

Earnings History and Estimates for MedEquities Realty Trust (NYSE:MRT)

Receive News & Stock Ratings for MedEquities Realty Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MedEquities Realty Trust and related stocks with our FREE daily email newsletter.